@article{11190,
  keywords = {Humans, *Hyperuricemia/drug therapy/blood/epidemiology/complications, Male, *Heart Failure/epidemiology/drug therapy/mortality, Female, Aged, United Kingdom/epidemiology, Retrospective Studies, *Uric Acid/blood, *Gout Suppressants/therapeutic use, Risk Factors, Middle Aged, Biomarkers/blood, Treatment Outcome, Gout/drug therapy/blood/complications/epidemiology, Time Factors, Databases, Factual, Follow-Up Studies, gout, heart failure, hyperuricemia, urate‐lowering therapy, analysis and manuscript development.},
  author = {S. Kiddle and K. Sundell and S. Perl and S. Nolan and M. Bjursell},
  title = {Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink},
  year = {2024},
  journal = {Clin Cardiol},
  volume = {47},
  edition = {2024/06/14},
  number = {6},
  pages = {e24297},
  isbn = {0160-9289 (Print)
0160-9289},
  doi = {10.1002/clc.24297},
  note = {1932-8737
Kiddle, Steven J
Orcid: 0000-0003-4350-7437
Sundell, Karolina Andersson
Perl, Shira
Nolan, Stephen
Bjursell, Magnus
AstraZeneca/
Journal Article
Multicenter Study
United States
Clin Cardiol. 2024 Jun;47(6):e24297. doi: 10.1002/clc.24297.},
  language = {eng},
}